Get Real Time Here
| Open22.700 | Close22.750 |
| Vol / Avg.2.526M / 4.691M | Mkt Cap5.226B |
| Day Range22.670 - 22.800 | 52 Wk Range12.480 - 25.320 |
Abcam Stock (NASDAQ:ABCM), Quotes and News Summary
Abcam Stock (NASDAQ: ABCM) stock price, news, charts, stock research, profile.
| Open22.700 | Close22.750 |
| Vol / Avg.2.526M / 4.691M | Mkt Cap5.226B |
| Day Range22.670 - 22.800 | 52 Wk Range12.480 - 25.320 |
Earnings
see more| H1 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | 0.210 | ||||||
| REV | 221.474M |
| FY 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | 0.310 | ||||||
| REV | 447.630M |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-08-30 | SVB Leerink | Puneet Souda | Downgrades | OutperformMarket Perform | Announces | - | 24.00 |
| 2023-08-22 | RBC Capital | Alistair Campbell | Reiterates | Sector PerformSector Perform | Maintains | - | 25.00 |
| 2023-06-20 | RBC Capital | Alistair Campbell | Downgrades | OutperformSector Perform | Lowers | 23.00 | 22.00 |
| 2023-06-16 | B of A Securities | Michael Ryskin | Upgrades | NeutralBuy | Announces | - | 25.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| ABCM | Abcam | 0.26% | 5.2B |
| IMVT | Immunovant | 1.05% | 4.5B |
| LEGN | Legend Biotech | -1.37% | 11.6B |
| EXAS | Exact Sciences | -0.84% | 11.8B |
| SRPT | Sarepta Therapeutics | -2.19% | 11B |
How do I buy Abcam (ABCM) stock?
You can purchase shares of Abcam (NASDAQ: ABCM) through any online brokerage.
Who are Abcam's (ABCM) competitors?
Other companies in Abcam’s space includes: Immunovant (NASDAQ:IMVT), Legend Biotech (NASDAQ:LEGN), Exact Sciences (NASDAQ:EXAS), Sarepta Therapeutics (NASDAQ:SRPT) and Neurocrine Biosciences (NASDAQ:NBIX).
What is the target price for Abcam (ABCM) stock?
The latest price target for Abcam (NASDAQ: ABCM) was reported by SVB Leerink on Wednesday, August 30, 2023. The analyst firm set a price target for 24.00 expecting ABCM to rise to within 12 months (a possible 5.49% upside). 9 analyst firms have reported ratings in the last year.
Current Stock Price for Abcam (ABCM)?
The stock price for Abcam (NASDAQ: ABCM) is $22.75 last updated October 4, 2023 at 8:00 PM UTC.
Does Abcam (ABCM) pay a dividend?
There is no dividend information for Abcam.
When is Abcam (NASDAQ:ABCM) reporting earnings?
Abcam’s H1 earnings are confirmed for Thursday, August 31, 2023.
Is Abcam (ABCM) going to split?
There is no upcoming split for Abcam.
What sector and industry does Abcam (ABCM) operate in?
Abcam is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Abcam Stock (NASDAQ:ABCM), Quotes and News Summary
Abcam Stock (NASDAQ: ABCM) stock price, news, charts, stock research, profile.
| Open22.700 | Close22.750 |
| Vol / Avg.2.526M / 4.691M | Mkt Cap5.226B |
| Day Range22.670 - 22.800 | 52 Wk Range12.480 - 25.320 |
Earnings
see more| H1 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | 0.210 | ||||||
| REV | 221.474M |
| FY 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | 0.310 | ||||||
| REV | 447.630M |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-08-30 | SVB Leerink | Puneet Souda | Downgrades | OutperformMarket Perform | Announces | - | 24.00 |
| 2023-08-22 | RBC Capital | Alistair Campbell | Reiterates | Sector PerformSector Perform | Maintains | - | 25.00 |
| 2023-06-20 | RBC Capital | Alistair Campbell | Downgrades | OutperformSector Perform | Lowers | 23.00 | 22.00 |
| 2023-06-16 | B of A Securities | Michael Ryskin | Upgrades | NeutralBuy | Announces | - | 25.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| ABCM | Abcam | 0.26% | 5.2B |
| IMVT | Immunovant | 1.05% | 4.5B |
| LEGN | Legend Biotech | -1.37% | 11.6B |
| EXAS | Exact Sciences | -0.84% | 11.8B |
| SRPT | Sarepta Therapeutics | -2.19% | 11B |
How do I buy Abcam (ABCM) stock?
You can purchase shares of Abcam (NASDAQ: ABCM) through any online brokerage.
Who are Abcam's (ABCM) competitors?
Other companies in Abcam’s space includes: Immunovant (NASDAQ:IMVT), Legend Biotech (NASDAQ:LEGN), Exact Sciences (NASDAQ:EXAS), Sarepta Therapeutics (NASDAQ:SRPT) and Neurocrine Biosciences (NASDAQ:NBIX).
What is the target price for Abcam (ABCM) stock?
The latest price target for Abcam (NASDAQ: ABCM) was reported by SVB Leerink on Wednesday, August 30, 2023. The analyst firm set a price target for 24.00 expecting ABCM to rise to within 12 months (a possible 5.49% upside). 9 analyst firms have reported ratings in the last year.
Current Stock Price for Abcam (ABCM)?
The stock price for Abcam (NASDAQ: ABCM) is $22.75 last updated October 4, 2023 at 8:00 PM UTC.
Does Abcam (ABCM) pay a dividend?
There is no dividend information for Abcam.
When is Abcam (NASDAQ:ABCM) reporting earnings?
Abcam’s H1 earnings are confirmed for Thursday, August 31, 2023.
Is Abcam (ABCM) going to split?
There is no upcoming split for Abcam.
What sector and industry does Abcam (ABCM) operate in?
Abcam is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Abcam Stock (NASDAQ:ABCM), Quotes and News Summary
Abcam Stock (NASDAQ: ABCM) stock price, news, charts, stock research, profile.
| Open22.700 | Close22.750 |
| Vol / Avg.2.526M / 4.691M | Mkt Cap5.226B |
| Day Range22.670 - 22.800 | 52 Wk Range12.480 - 25.320 |
Earnings
see more| H1 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | 0.210 | ||||||
| REV | 221.474M |
| FY 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | 0.310 | ||||||
| REV | 447.630M |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-08-30 | SVB Leerink | Puneet Souda | Downgrades | OutperformMarket Perform | Announces | - | 24.00 |
| 2023-08-22 | RBC Capital | Alistair Campbell | Reiterates | Sector PerformSector Perform | Maintains | - | 25.00 |
| 2023-06-20 | RBC Capital | Alistair Campbell | Downgrades | OutperformSector Perform | Lowers | 23.00 | 22.00 |
| 2023-06-16 | B of A Securities | Michael Ryskin | Upgrades | NeutralBuy | Announces | - | 25.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| ABCM | Abcam | 0.26% | 5.2B |
| IMVT | Immunovant | 1.05% | 4.5B |
| LEGN | Legend Biotech | -1.37% | 11.6B |
| EXAS | Exact Sciences | -0.84% | 11.8B |
| SRPT | Sarepta Therapeutics | -2.19% | 11B |
How do I buy Abcam (ABCM) stock?
You can purchase shares of Abcam (NASDAQ: ABCM) through any online brokerage.
Who are Abcam's (ABCM) competitors?
Other companies in Abcam’s space includes: Immunovant (NASDAQ:IMVT), Legend Biotech (NASDAQ:LEGN), Exact Sciences (NASDAQ:EXAS), Sarepta Therapeutics (NASDAQ:SRPT) and Neurocrine Biosciences (NASDAQ:NBIX).
What is the target price for Abcam (ABCM) stock?
The latest price target for Abcam (NASDAQ: ABCM) was reported by SVB Leerink on Wednesday, August 30, 2023. The analyst firm set a price target for 24.00 expecting ABCM to rise to within 12 months (a possible 5.49% upside). 9 analyst firms have reported ratings in the last year.
Current Stock Price for Abcam (ABCM)?
The stock price for Abcam (NASDAQ: ABCM) is $22.75 last updated October 4, 2023 at 8:00 PM UTC.
Does Abcam (ABCM) pay a dividend?
There is no dividend information for Abcam.
When is Abcam (NASDAQ:ABCM) reporting earnings?
Abcam’s H1 earnings are confirmed for Thursday, August 31, 2023.
Is Abcam (ABCM) going to split?
There is no upcoming split for Abcam.
What sector and industry does Abcam (ABCM) operate in?
Abcam is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Abcam Stock (NASDAQ:ABCM), Quotes and News Summary
Abcam Stock (NASDAQ: ABCM) stock price, news, charts, stock research, profile.
| Open22.700 | Close22.750 |
| Vol / Avg.2.526M / 4.691M | Mkt Cap5.226B |
| Day Range22.670 - 22.800 | 52 Wk Range12.480 - 25.320 |
Earnings
see more| H1 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | 0.210 | ||||||
| REV | 221.474M |
| FY 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | 0.310 | ||||||
| REV | 447.630M |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-08-30 | SVB Leerink | Puneet Souda | Downgrades | OutperformMarket Perform | Announces | - | 24.00 |
| 2023-08-22 | RBC Capital | Alistair Campbell | Reiterates | Sector PerformSector Perform | Maintains | - | 25.00 |
| 2023-06-20 | RBC Capital | Alistair Campbell | Downgrades | OutperformSector Perform | Lowers | 23.00 | 22.00 |
| 2023-06-16 | B of A Securities | Michael Ryskin | Upgrades | NeutralBuy | Announces | - | 25.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| ABCM | Abcam | 0.26% | 5.2B |
| IMVT | Immunovant | 1.05% | 4.5B |
| LEGN | Legend Biotech | -1.37% | 11.6B |
| EXAS | Exact Sciences | -0.84% | 11.8B |
| SRPT | Sarepta Therapeutics | -2.19% | 11B |
How do I buy Abcam (ABCM) stock?
You can purchase shares of Abcam (NASDAQ: ABCM) through any online brokerage.
Who are Abcam's (ABCM) competitors?
Other companies in Abcam’s space includes: Immunovant (NASDAQ:IMVT), Legend Biotech (NASDAQ:LEGN), Exact Sciences (NASDAQ:EXAS), Sarepta Therapeutics (NASDAQ:SRPT) and Neurocrine Biosciences (NASDAQ:NBIX).
What is the target price for Abcam (ABCM) stock?
The latest price target for Abcam (NASDAQ: ABCM) was reported by SVB Leerink on Wednesday, August 30, 2023. The analyst firm set a price target for 24.00 expecting ABCM to rise to within 12 months (a possible 5.49% upside). 9 analyst firms have reported ratings in the last year.
Current Stock Price for Abcam (ABCM)?
The stock price for Abcam (NASDAQ: ABCM) is $22.75 last updated October 4, 2023 at 8:00 PM UTC.
Does Abcam (ABCM) pay a dividend?
There is no dividend information for Abcam.
When is Abcam (NASDAQ:ABCM) reporting earnings?
Abcam’s H1 earnings are confirmed for Thursday, August 31, 2023.
Is Abcam (ABCM) going to split?
There is no upcoming split for Abcam.
What sector and industry does Abcam (ABCM) operate in?
Abcam is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Abcam Stock (NASDAQ:ABCM), Quotes and News Summary
Abcam Stock (NASDAQ: ABCM) stock price, news, charts, stock research, profile.
| Open22.700 | Close22.750 |
| Vol / Avg.2.526M / 4.691M | Mkt Cap5.226B |
| Day Range22.670 - 22.800 | 52 Wk Range12.480 - 25.320 |
Earnings
see more| H1 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | 0.210 | ||||||
| REV | 221.474M |
| FY 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | 0.310 | ||||||
| REV | 447.630M |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-08-30 | SVB Leerink | Puneet Souda | Downgrades | OutperformMarket Perform | Announces | - | 24.00 |
| 2023-08-22 | RBC Capital | Alistair Campbell | Reiterates | Sector PerformSector Perform | Maintains | - | 25.00 |
| 2023-06-20 | RBC Capital | Alistair Campbell | Downgrades | OutperformSector Perform | Lowers | 23.00 | 22.00 |
| 2023-06-16 | B of A Securities | Michael Ryskin | Upgrades | NeutralBuy | Announces | - | 25.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| ABCM | Abcam | 0.26% | 5.2B |
| IMVT | Immunovant | 1.05% | 4.5B |
| LEGN | Legend Biotech | -1.37% | 11.6B |
| EXAS | Exact Sciences | -0.84% | 11.8B |
| SRPT | Sarepta Therapeutics | -2.19% | 11B |
How do I buy Abcam (ABCM) stock?
You can purchase shares of Abcam (NASDAQ: ABCM) through any online brokerage.
Who are Abcam's (ABCM) competitors?
Other companies in Abcam’s space includes: Immunovant (NASDAQ:IMVT), Legend Biotech (NASDAQ:LEGN), Exact Sciences (NASDAQ:EXAS), Sarepta Therapeutics (NASDAQ:SRPT) and Neurocrine Biosciences (NASDAQ:NBIX).
What is the target price for Abcam (ABCM) stock?
The latest price target for Abcam (NASDAQ: ABCM) was reported by SVB Leerink on Wednesday, August 30, 2023. The analyst firm set a price target for 24.00 expecting ABCM to rise to within 12 months (a possible 5.49% upside). 9 analyst firms have reported ratings in the last year.
Current Stock Price for Abcam (ABCM)?
The stock price for Abcam (NASDAQ: ABCM) is $22.75 last updated October 4, 2023 at 8:00 PM UTC.
Does Abcam (ABCM) pay a dividend?
There is no dividend information for Abcam.
When is Abcam (NASDAQ:ABCM) reporting earnings?
Abcam’s H1 earnings are confirmed for Thursday, August 31, 2023.
Is Abcam (ABCM) going to split?
There is no upcoming split for Abcam.
What sector and industry does Abcam (ABCM) operate in?
Abcam is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Abcam Stock (NASDAQ:ABCM), Quotes and News Summary
Abcam Stock (NASDAQ: ABCM) stock price, news, charts, stock research, profile.
| Open22.700 | Close22.750 |
| Vol / Avg.2.526M / 4.691M | Mkt Cap5.226B |
| Day Range22.670 - 22.800 | 52 Wk Range12.480 - 25.320 |
Earnings
see more| H1 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | 0.210 | ||||||
| REV | 221.474M |
| FY 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | 0.310 | ||||||
| REV | 447.630M |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-08-30 | SVB Leerink | Puneet Souda | Downgrades | OutperformMarket Perform | Announces | - | 24.00 |
| 2023-08-22 | RBC Capital | Alistair Campbell | Reiterates | Sector PerformSector Perform | Maintains | - | 25.00 |
| 2023-06-20 | RBC Capital | Alistair Campbell | Downgrades | OutperformSector Perform | Lowers | 23.00 | 22.00 |
| 2023-06-16 | B of A Securities | Michael Ryskin | Upgrades | NeutralBuy | Announces | - | 25.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| ABCM | Abcam | 0.26% | 5.2B |
| IMVT | Immunovant | 1.05% | 4.5B |
| LEGN | Legend Biotech | -1.37% | 11.6B |
| EXAS | Exact Sciences | -0.84% | 11.8B |
| SRPT | Sarepta Therapeutics | -2.19% | 11B |
How do I buy Abcam (ABCM) stock?
You can purchase shares of Abcam (NASDAQ: ABCM) through any online brokerage.
Who are Abcam's (ABCM) competitors?
Other companies in Abcam’s space includes: Immunovant (NASDAQ:IMVT), Legend Biotech (NASDAQ:LEGN), Exact Sciences (NASDAQ:EXAS), Sarepta Therapeutics (NASDAQ:SRPT) and Neurocrine Biosciences (NASDAQ:NBIX).
What is the target price for Abcam (ABCM) stock?
The latest price target for Abcam (NASDAQ: ABCM) was reported by SVB Leerink on Wednesday, August 30, 2023. The analyst firm set a price target for 24.00 expecting ABCM to rise to within 12 months (a possible 5.49% upside). 9 analyst firms have reported ratings in the last year.
Current Stock Price for Abcam (ABCM)?
The stock price for Abcam (NASDAQ: ABCM) is $22.75 last updated October 4, 2023 at 8:00 PM UTC.
Does Abcam (ABCM) pay a dividend?
There is no dividend information for Abcam.
When is Abcam (NASDAQ:ABCM) reporting earnings?
Abcam’s H1 earnings are confirmed for Thursday, August 31, 2023.
Is Abcam (ABCM) going to split?
There is no upcoming split for Abcam.
What sector and industry does Abcam (ABCM) operate in?
Abcam is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Abcam Stock (NASDAQ:ABCM), Quotes and News Summary
Abcam Stock (NASDAQ: ABCM) stock price, news, charts, stock research, profile.
| Open22.700 | Close22.750 |
| Vol / Avg.2.526M / 4.691M | Mkt Cap5.226B |
| Day Range22.670 - 22.800 | 52 Wk Range12.480 - 25.320 |
Earnings
see more| H1 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | 0.210 | ||||||
| REV | 221.474M |
| FY 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | 0.310 | ||||||
| REV | 447.630M |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-08-30 | SVB Leerink | Puneet Souda | Downgrades | OutperformMarket Perform | Announces | - | 24.00 |
| 2023-08-22 | RBC Capital | Alistair Campbell | Reiterates | Sector PerformSector Perform | Maintains | - | 25.00 |
| 2023-06-20 | RBC Capital | Alistair Campbell | Downgrades | OutperformSector Perform | Lowers | 23.00 | 22.00 |
| 2023-06-16 | B of A Securities | Michael Ryskin | Upgrades | NeutralBuy | Announces | - | 25.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| ABCM | Abcam | 0.26% | 5.2B |
| IMVT | Immunovant | 1.05% | 4.5B |
| LEGN | Legend Biotech | -1.37% | 11.6B |
| EXAS | Exact Sciences | -0.84% | 11.8B |
| SRPT | Sarepta Therapeutics | -2.19% | 11B |
How do I buy Abcam (ABCM) stock?
You can purchase shares of Abcam (NASDAQ: ABCM) through any online brokerage.
Who are Abcam's (ABCM) competitors?
Other companies in Abcam’s space includes: Immunovant (NASDAQ:IMVT), Legend Biotech (NASDAQ:LEGN), Exact Sciences (NASDAQ:EXAS), Sarepta Therapeutics (NASDAQ:SRPT) and Neurocrine Biosciences (NASDAQ:NBIX).
What is the target price for Abcam (ABCM) stock?
The latest price target for Abcam (NASDAQ: ABCM) was reported by SVB Leerink on Wednesday, August 30, 2023. The analyst firm set a price target for 24.00 expecting ABCM to rise to within 12 months (a possible 5.49% upside). 9 analyst firms have reported ratings in the last year.
Current Stock Price for Abcam (ABCM)?
The stock price for Abcam (NASDAQ: ABCM) is $22.75 last updated October 4, 2023 at 8:00 PM UTC.
Does Abcam (ABCM) pay a dividend?
There is no dividend information for Abcam.
When is Abcam (NASDAQ:ABCM) reporting earnings?
Abcam’s H1 earnings are confirmed for Thursday, August 31, 2023.
Is Abcam (ABCM) going to split?
There is no upcoming split for Abcam.
What sector and industry does Abcam (ABCM) operate in?
Abcam is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Abcam Stock (NASDAQ:ABCM), Quotes and News Summary
Abcam Stock (NASDAQ: ABCM) stock price, news, charts, stock research, profile.
| Open22.700 | Close22.750 |
| Vol / Avg.2.526M / 4.691M | Mkt Cap5.226B |
| Day Range22.670 - 22.800 | 52 Wk Range12.480 - 25.320 |
Earnings
see more| H1 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | 0.210 | ||||||
| REV | 221.474M |
| FY 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | 0.310 | ||||||
| REV | 447.630M |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-08-30 | SVB Leerink | Puneet Souda | Downgrades | OutperformMarket Perform | Announces | - | 24.00 |
| 2023-08-22 | RBC Capital | Alistair Campbell | Reiterates | Sector PerformSector Perform | Maintains | - | 25.00 |
| 2023-06-20 | RBC Capital | Alistair Campbell | Downgrades | OutperformSector Perform | Lowers | 23.00 | 22.00 |
| 2023-06-16 | B of A Securities | Michael Ryskin | Upgrades | NeutralBuy | Announces | - | 25.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| ABCM | Abcam | 0.26% | 5.2B |
| IMVT | Immunovant | 1.05% | 4.5B |
| LEGN | Legend Biotech | -1.37% | 11.6B |
| EXAS | Exact Sciences | -0.84% | 11.8B |
| SRPT | Sarepta Therapeutics | -2.19% | 11B |
How do I buy Abcam (ABCM) stock?
You can purchase shares of Abcam (NASDAQ: ABCM) through any online brokerage.
Who are Abcam's (ABCM) competitors?
Other companies in Abcam’s space includes: Immunovant (NASDAQ:IMVT), Legend Biotech (NASDAQ:LEGN), Exact Sciences (NASDAQ:EXAS), Sarepta Therapeutics (NASDAQ:SRPT) and Neurocrine Biosciences (NASDAQ:NBIX).
What is the target price for Abcam (ABCM) stock?
The latest price target for Abcam (NASDAQ: ABCM) was reported by SVB Leerink on Wednesday, August 30, 2023. The analyst firm set a price target for 24.00 expecting ABCM to rise to within 12 months (a possible 5.49% upside). 9 analyst firms have reported ratings in the last year.
Current Stock Price for Abcam (ABCM)?
The stock price for Abcam (NASDAQ: ABCM) is $22.75 last updated October 4, 2023 at 8:00 PM UTC.
Does Abcam (ABCM) pay a dividend?
There is no dividend information for Abcam.
When is Abcam (NASDAQ:ABCM) reporting earnings?
Abcam’s H1 earnings are confirmed for Thursday, August 31, 2023.
Is Abcam (ABCM) going to split?
There is no upcoming split for Abcam.
What sector and industry does Abcam (ABCM) operate in?
Abcam is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Abcam Stock (NASDAQ:ABCM), Quotes and News Summary
Abcam Stock (NASDAQ: ABCM) stock price, news, charts, stock research, profile.
| Open22.700 | Close22.750 |
| Vol / Avg.2.526M / 4.691M | Mkt Cap5.226B |
| Day Range22.670 - 22.800 | 52 Wk Range12.480 - 25.320 |
Earnings
see more| H1 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | 0.210 | ||||||
| REV | 221.474M |
| FY 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | 0.310 | ||||||
| REV | 447.630M |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-08-30 | SVB Leerink | Puneet Souda | Downgrades | OutperformMarket Perform | Announces | - | 24.00 |
| 2023-08-22 | RBC Capital | Alistair Campbell | Reiterates | Sector PerformSector Perform | Maintains | - | 25.00 |
| 2023-06-20 | RBC Capital | Alistair Campbell | Downgrades | OutperformSector Perform | Lowers | 23.00 | 22.00 |
| 2023-06-16 | B of A Securities | Michael Ryskin | Upgrades | NeutralBuy | Announces | - | 25.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| ABCM | Abcam | 0.26% | 5.2B |
| IMVT | Immunovant | 1.05% | 4.5B |
| LEGN | Legend Biotech | -1.37% | 11.6B |
| EXAS | Exact Sciences | -0.84% | 11.8B |
| SRPT | Sarepta Therapeutics | -2.19% | 11B |
How do I buy Abcam (ABCM) stock?
You can purchase shares of Abcam (NASDAQ: ABCM) through any online brokerage.
Who are Abcam's (ABCM) competitors?
Other companies in Abcam’s space includes: Immunovant (NASDAQ:IMVT), Legend Biotech (NASDAQ:LEGN), Exact Sciences (NASDAQ:EXAS), Sarepta Therapeutics (NASDAQ:SRPT) and Neurocrine Biosciences (NASDAQ:NBIX).
What is the target price for Abcam (ABCM) stock?
The latest price target for Abcam (NASDAQ: ABCM) was reported by SVB Leerink on Wednesday, August 30, 2023. The analyst firm set a price target for 24.00 expecting ABCM to rise to within 12 months (a possible 5.49% upside). 9 analyst firms have reported ratings in the last year.
Current Stock Price for Abcam (ABCM)?
The stock price for Abcam (NASDAQ: ABCM) is $22.75 last updated October 4, 2023 at 8:00 PM UTC.
Does Abcam (ABCM) pay a dividend?
There is no dividend information for Abcam.
When is Abcam (NASDAQ:ABCM) reporting earnings?
Abcam’s H1 earnings are confirmed for Thursday, August 31, 2023.
Is Abcam (ABCM) going to split?
There is no upcoming split for Abcam.
What sector and industry does Abcam (ABCM) operate in?
Abcam is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.